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Abstract
Many genetic variants influence complex traits by modulating gene expression, thus altering the 
abundance levels of one or multiple proteins. Here, we introduce a powerful strategy that 
integrates gene expression measurements with summary association statistics from large-scale 
genome-wide association studies (GWAS) to identify genes whose cis-regulated expression is 
associated to complex traits. We leverage expression imputation to perform a transcriptome wide 
association scan (TWAS) to identify significant expression-trait associations. We applied our 
approaches to expression data from blood and adipose tissue measured in ~3,000 individuals 
overall. We imputed gene expression into GWAS data from over 900,000 phenotype 
measurements to identify 69 novel genes significantly associated to obesity-related traits (BMI, 
lipids, and height). Many of the novel genes are associated with relevant phenotypes in the Hybrid 
Mouse Diversity Panel. Our results showcase the power of integrating genotype, gene expression 
and phenotype to gain insights into the genetic basis of complex traits.
Introduction
Although a large proportion of variability in complex human traits is due to genetic 
variation, the mechanistic steps between genetic variation and trait are generally not 
understood1–7. Many genetic variants influence complex traits by modulating gene 
expression, thus altering the abundance levels of one or multiple proteins8–12. Such 
relationships between expression and trait could be investigated through association scans in 
individuals for which both measurements are available8,13,14. Unfortunately, studies that 
measure gene expression have been held back by specimen availability and cost, with the 
few published studies of expression and complex trait being orders of magnitude smaller 
than studies of trait alone. Consequently, many expression-trait associations cannot be 
detected, especially those with small effects. To mitigate the reduced power from small 
sample size, alternative approaches examined the overlap of genetic variants that impact 
gene expression (eQTLs) with trait-associated variants identified in large, independent 
genome-wide association studies (GWAS)5,6,8,9,11–13,15. However, this approach is also 
likely to miss expression-trait associations of small effect.
We developed a new approach to identify genes whose expression is significantly associated 
to complex traits in individuals without directly measured expression levels (Methods). We 
leveraged a relatively small set of reference individuals for whom both gene expression and 
genetic variation (single nucleotide polymorphisms, SNPs) have been measured to impute 
the cis-genetic component of expression into a much larger set of phenotyped individuals 
from their SNP genotype data (Figure 1). The imputed expression can be viewed as a linear 
model of genotypes with weights based on the correlation between SNPs and gene 
expression in the training data while accounting for linkage disequilibrium (LD) among 
SNPs. We then correlated the imputed gene expression to the trait to perform a 
transcriptome-wide association study (TWAS) and identify significant expression-trait 
associations (Methods). Work in parallel to ours has also proposed to find expression-trait 
associations through imputation of gene expression when GWAS at an individual level is 
available16(see Discussion). However, a critical limitation is that large-scale GWAS data are 
typically only publicly available at the level of summary association statistics (e.g. 
Gusev et al. Page 2
Nat Genet. Author manuscript; available in PMC 2017 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
individual SNP effect sizes)2–4. To capitalize on the largest GWAS to date (typically 
available only at the summary level), we extended our approach to impute the expression-
trait association statistics directly from GWAS summary statistics (Methods). In contrast to 
expression imputation from individual-level data16, imputation of expression-trait 
association from GWAS summary statistics can exploit publically available data from 
hundreds of thousands of samples. Linear predictors naturally extend to indirect imputation 
of the standardized effect of the cis-genetic component on the trait starting from only the 
GWAS association statistics2–4 (Methods). This allowed us to increase the effective sample 
size for expression-trait association testing to hundreds of thousands of individuals. By 
focusing only on the genetic component of expression, we avoid instances of expression-
trait associations that are not a consequence of genetic variation but are driven by variation 
in trait (Figure 2). Our approach can be conceptualized as a test for significant cis-genetic 
correlation between expression and trait (see Results).
We applied our approaches to expression data from blood and adipose tissue measured in 
~3,000 individuals overall. Through extensive simulations and real data analyses we show 
that our proposed approach increases performance over standard GWAS or eQTL-guided 
GWAS. Furthermore, we reanalyzed a 2010 lipid GWAS17 to find 25 new expression-trait 
associations in that data. 19 out of 25 contained genome-wide significant SNPs in the more 
recent and expanded lipids study5 thus showcasing the power of our approach to find robust 
associations. We imputed gene expression into GWAS data from over 900,000 phenotype 
measurements5–7 to identify 69 novel genes significantly associated to obesity-related traits 
(BMI, lipids, and height). Many of the novel genes were associated with relevant 
phenotypes in the Hybrid Mouse Diversity Panel. Overall our results showcase the power of 
integrating genotype, gene expression and phenotype to gain insights into the genetic basis 
of complex traits.
Results
SNP-heritability of gene expression
To investigate the potential utility of a transcriptome-wide association (TWAS) based on 
imputed gene expression we first estimated the cis- (1Mb window around the gene) and 
trans- (rest of the genome) SNP-heritability ( ) for each gene in our data18,19. 
These metrics quantify the maximum possible accuracy (in terms of R2) of a linear predictor 
from the corresponding set of SNPs20,21 (Methods). We used 3,234 individuals for whom 
genome-wide SNP data and expression measurements were available from METSIM 
(adipose), YFS (blood), and NTR (blood) data sets22–24 (Methods, Supplementary Table 1). 
All expression measurements were adjusted for batch confounders, and array probes were 
merged into a single expression value for each gene where possible (Methods). Consistent 
with previous work24,25, we observed significantly non-zero estimates of heritability across 
all three studies, with mean  ranging from 0.01–0.07 and mean  ranging from 
0.04–0.06 in genes where estimates converged (Supplementary Figure 1, Supplementary 
Table 1). Although we observed large differences in the average  estimates between the 
two blood cohorts, the estimates were strongly correlated across genes (Pearson ρ=0.47 for 
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YFS-NTR, as compared to ρ=0.15 and ρ=0.26 for METSIM-NTR and METSIM-YFS 
respectively). This is consistent with a common but not identical genetic architecture. The 
 was significantly non-zero for 6,924 genes after accounting for multiple hypotheses 
(1,985 for METSIM, 3,836 for YFS, and 1,103 for NTR) (Supplementary Figure 1) whereas 
current sample sizes where too small to detect individually significant trans heritable genes. 
As expected, we also observed a high overlap of genes with significant  across cohorts 
(Supplementary Table 2, Supplementary Figure 2). We focused subsequent analyses on the 
6,924 cis-heritable genes as such genes are typically enriched for trait 
associations7,9,13,24–29.
TWAS performance in simulation and cross-validation
We evaluated whether the expressions of the 6,924 highly heritable genes could be 
accurately imputed from cis-SNP genotype data alone in these three cohorts. In each tissue, 
we used cross-validation to compare predictions from the best cis-eQTL to those from all 
SNPs at the locus either in a best linear unbiased predictor (BLUP) or in a Bayesian 
model30,31 (Methods). On average, the Bayesian linear mixed model (BSLMM)31, which 
uses all cis-SNPs and estimates the underlying effect-size distribution, attained the best 
performance with a 32% gain in prediction R2 over a prediction computed using only the top 
cis-eQTL (Figure 4, Supplementary Figure 3). The BSLMM exhibited a long tail of 
increased accuracy, more than doubling the prediction R2 for 25% of genes (Supplementary 
Figure 4). In contrast to complex traits where hundreds of thousands of training samples are 
required for accurate prediction32,33, a substantial portion of variance in expression can be 
predicted at current sample sizes due to the much smaller number of independent SNPs in 
the cis region21. Furthermore, larger training sizes will continue to increase the total number 
of genes that can be accurately predicted (Figure 3). We further evaluated cross-cohort 
prediction of these genes in the YFS and NTR, which were roughly equally sized and had 
expression measured in whole-blood by microarray, but were genotyped on different 
platforms and from different Scandinavian populations. After accounting for cis-heritability 
in the test cohort, our cross-cohort standardized accuracy (i.e. ) was broadly 
consistent with in-cohort cross-validation accuracy (Supplementary Table 3). The BSLMM 
was again the most accurate predictor, with an average cross-cohort  of 72%, 
outperforming the best eQTL by an average 1.17x.
Next, we focused on evaluating the power of the TWAS approach to detect significant 
expression-trait associations using GWAS summary data from complex traits (equivalent to 
TWAS from individual level data; Methods, Supplementary Figure 5). For comparison, we 
also measured power to detect significant SNP-trait associations through standard GWAS 
(testing each SNP individually) and eQTL-based GWAS (eGWAS, where the best eQTL in 
each gene is the only variant tested for association to trait), with all three tests corrected for 
their genome-wide testing burdens. Using real genotype data, we simulated a causal SNP-
expression-trait model with realistic effect-sizes and measured the power of each strategy to 
identify genome-wide significant variants (accounting for 1 million SNPs for GWAS and 
15,000 expressed genes using family-wise error rate control). Over many diverse disease 
architectures TWAS substantially increased power when the expression-causing variants 
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were un-typed or poorly tagged by an individual SNP (Figure 5, Supplementary Figures 6–
11). The greatest power gains were observed in the case of multiple causal variants: 92% 
power for TWAS compared to 18% and 25% for GWAS and eGWAS. This scenario would 
correspond to expression caused by allelic heterogeneity9,34,35, or “apparent” heterogeneity 
at common variants (due to tagging of unobserved causal variant)36. TWAS was comparable 
to other approaches when a single causal variant was directly typed, in which case 
combining the effects of neighboring SNPs does not add signal. Under the null where 
expression was completely independent of phenotype (with either being heritable, Figure 
2A–D), the TWAS false positive rate was well controlled (Supplementary Table 4). As 
expected, all methods were confounded in the case where the same causal variants had 
independent effects on trait and expression (Figure 2F–G; Supplementary Figures S8, 12).
Our approach can be conceptually viewed as a test for the correlation between the genetic 
component of expression and the genetic component of trait (Methods). Since several recent 
methods have been proposed that measure genetic correlation between summary statistics37, 
we sought to evaluate this relationship empirically. We compared TWAS to the recently 
proposed cross-trait LD-score regression (LDSC) that estimates genome-wide genetic 
correlation between traits37. Although LDSC is not intended for local analyses due to model 
assumptions on polygenicity and use of block-jackknife across loci for estimating standard 
errors, we performed the evaluation using expression and phenotype (height) from the YFS 
cohort, using the results over individual data as the “gold standard” (Methods). We find that 
LDSC estimate of genetic correlation between height and expression from summary data is 
highly correlated with the gold standard (correlation=0.7, Supplementary Figure 13), but the 
relationship is much noisier than that of TWAS (correlation=0.99, Supplementary Figure 5, 
13). This suggests that TWAS attains more power in relating expression to complex traits.
TWAS is also conceptually similar a test for co-localization of signal between expression 
and complex trait38,39, and we compared to a recently proposed method, COLOC38, that 
evaluates co-localization of expression at known GWAS risk loci. After matching the false-
discovery rate of the two methods in simulations (Methods), TWAS and COLOC had 
similar power under the single typed causal variant scenario (with slightly lower COLOC 
power at small GWAS sizes), but TWAS has superior performance when the causal variant 
was un-typed or in the presence of allelic heterogeneity (Supplementary Figure 10). This is 
likely due the fact that TWAS explicitly models LD to better capture the un-typed variants.
Finally, we investigated the effect of the expression reference panel size on performance of 
TWAS (Supplementary Figure 9). In general, TWAS always outperforms eGWAS when 
multiple variants are causal. Interestingly, power for either approaches does not increase 
substantially beyond 1,000 expression samples, suggesting that the expression panels 
analyzed in this manuscript nearly saturate the available imputation accuracy. This was 
further reflected in an analysis of real data where merging cohorts did not substantially 
change the distribution of TWAS statistics for the same gene set (Supplementary Figure 14). 
Although these results come with caveats (e.g. standard assumptions of additive effects and 
normal residuals), they suggest that the main benefit of larger expression reference panels is 
in increasing the total number of significant cis-heritable genes available for imputation 
(Figure 3).
Gusev et al. Page 5
Nat Genet. Author manuscript; available in PMC 2017 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
TWAS performance in GWAS summary data
We employed TWAS to identify expression-trait associations at the 697 known GWAS risk 
loci for height7 using the YFS data for which height was also measured. At each locus, we 
considered three strategies for selecting a single causal gene: 1) the gene nearest to the top 
GWAS SNP; 2) the gene for which the index SNP is the strongest eQTL in the training data; 
3) the most significant TWAS gene. For each strategy, we then constructed a risk-score 
using the genetic value of expression for the selected genes and correlated the risk score 
with height measurements in the YFS individuals (an independent sample from the original 
height GWAS, Supplementary Note). The R2 between the risk score and height was 0.038 
(nearest); 0.031 (eQTL); and 0.054 (TWAS); with TWAS significantly higher than the 
others in a joint model (Supplementary Table 5, Methods). When we re-computed the risk 
scores using TWAS values for expression from the NTR cohort (which introduces additional 
noise due to heterogeneity between the cohorts), TWAS remained significantly higher than 
the eQTL strategy, but was comparable to selecting the nearest gene (Supplementary Table 
5). This indicates that using expression from a different study to select genes still 
significantly explains variance, but is complementary (rather than superior) to selecting the 
nearest gene. Working from the assumption that genes with a higher cis-genetic correlation 
to phenotype are more likely to be causal, these results motivate the use of TWAS to 
prioritize putative risk genes at known GWAS loci.
Across all known risk loci in our data, 77% of genome-wide significant loci (defined as lead 
SNP +/−500kb) overlapped at least one gene with significant , and 36% overlapped at 
least one significant TWAS association (Supplementary Table 6). These results suggest that 
cis regulation of expression in blood and adipose tissue is an important mechanism through 
which genetic variation at known risk loci alters obesity related traits. We expect that 
expression studies from other tissues relevant to obesity-related traits will further increase 
the overlap. Focusing specifically on the 282 TWAS genes that were within 500kb of the 
lead SNP, 187 (66%) are not the nearest gene with many residing more than 100kb away 
from the lead GWAS SNP (Supplementary Figure 15). Since GWAS usually reports the 
nearest gene, these 187 genes can be considered new candidates for follow-up at known risk 
loci. We note that gene-trait associations at known risk loci will not be found by TWAS 
either due to a causal mechanism that does not involve cis-expression of the tested genes, or 
lack of power to identify and detect all cis-heritable genes at the locus.
Next, we employed TWAS to identify novel expression-trait associations using summary 
association statistics from a 2010 lipid GWAS17 (~100,000 samples), i.e. associations more 
than 500Kb away from any genome-wide significant SNPs in that study. We used all three 
studies (METSIM, YFS, and NTR;) as separate SNP-expression training panels. We then 
looked for genome-wide significant SNPs at these loci in the larger 2013 lipid GWAS5 
(expanded to ~189,000 samples). We identified 25 such expression-trait associations in the 
2010 study (Supplementary Table 7), of which 19/25 contained genome-wide significant 
SNPs in the 2013 study (P=1×10−24 by hypergeometric test, Methods) and 24/25 contained 
a more significant SNP (P=1×10−04), a highly significant validation of the identified loci. 
The validation remained significant after conservatively accounting for sample overlap 
across the studies (binomial P=3×10−16; Methods, Supplementary Table 7). As a sanity 
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check, we compared direct and summary-level TWAS in the METSIM cohort, and found the 
two sets of imputed expression-trait Z-scores to be nearly identical, with summary-level 
TWAS slightly under-estimating the effect (Pearson ρ=0.96, Supplementary Figure 16). 
Overall, we find the TWAS approach to be highly predictive of robust phenotypic 
associations.
TWAS identifies novel expression-trait associations
Having established the utility of TWAS, we applied the approach to identify novel 
expression-trait associations using summary data from three recent GWAS over more than 
900,000 phenotype measurements: lipid measures (high-density lipoproteins [HDL] 
cholesterol, low-density lipoprotein [LDL] cholesterol, total cholesterol [TC], and 
triglycerides [TG])5; height7; and BMI6. Significantly cis-heritable genes across the three 
expression data sets were tested individually (6,924 tests) and together in an omnibus test 
that accounts for predictor correlation (1,075 tests; Methods), and we conservatively 
corrected for the 8,000 total tests performed for each trait. Overall, we identified 665 
significant gene-trait associations (Supplementary Table 8). Of these, 69 gene-trait 
associations did not overlap a genome-wide significant SNP in the corresponding GWAS, 
residing in 60 physically non-overlapping cis-loci (Table 1, Supplementary Table 9). 
Averaging over the novel genes, the Z2 statistics from TWAS were 1.5x higher than the 
strongest eQTL SNP for the same gene(though this may be slightly inflated due to winner’s 
curse). Our previous simulations suggest that the substantial gain over testing the cis-eQTL 
is an indication of pervasive allelic heterogeneity40 at these loci, and analyses of the 
expression showed strong evidence for allelic heterogeneity at the TWAS genes 
(Supplementary Figure 17).
We further sought to quantify the significance of the expression-trait associations 
conditional on the SNP-trait effects at the locus with a permutation test (Methods). 
Comparing to this null assesses how much signal is added by the true expression given the 
specific architecture of the locus. Of the 69 genes, this permutation test was significant for 
54 (after accounting for 69 tests). After excluding these individually significant genes, the P-
values were still substantially elevated with λGC of 19 (ratio of median χ2 to the expected 
null). For these 54 genes, we can confidently conclude that integration of expression data 
significantly refined the association to trait. As before, more evidence of allelic 
heterogeneity of expression was observed at the loci that passed permutation 
(Supplementary Figure 17). Our results are consistent with a model of causality where these 
genes harbor inherited causal variants that modulate expression, which in turn has a complex 
effect on the cell and downstream impact on complex traits6.
Next, we evaluated the contribution to heritability of all expression-trait associations, 
including those that were not genome-wide significant (Methods,29,30). We estimated the 
variance in trait explained by all METSIM+YFS imputed genes ( ) to be 3.4% averaged 
over six traits (Supplementary Table 10). We assumed independence between the two 
cohorts, and did not include the NTR genes because of its strong correlation with YFS. 
Height had the most variance attributable to the heritable genes at . These 
combined estimates were consistently higher than a corresponding analysis using predictions 
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from permuted expression (Supplementary Table 10). For the four traits with individual-
level genotype and phenotype data in the METSIM (BMI, TG, WHR, INS), we estimated 
 directly using variance-components over the imputed expression values (Methods). On 
average, all significantly heritable genes in adipose + blood explained 4–6% of the trait 
variance (16–19% of the total trait ), and were largely orthogonal between the two 
predictions (Supplementary Table 11). The imputed expression consistently explained more 
trait variance than the best cis-eQTL in each gene and did not strongly depend on the cis-
window size (Supplementary Table 12).
Re-evaluation using other expression cohorts
To replicate the 69 novel expression-trait associations, we re-evaluated the GWAS summary 
statistics with expression data from two external studies: eQTLs from ~900 samples in the 
MuTHER study25 of fat, LCL, and skin cells; and separate eQTL data from 5,311 samples 
across in whole blood11 (Methods). These expression studies only consist of summary-level 
associations, and are expected to be much noisier as reference. In the relatively smaller 
MuTHER sample, 20 out of 55 available genes replicated significantly in at least one tissue 
(after accounting for 55 tests, Supplementary Table 9). This is substantial given the apparent 
heterogeneity between cohorts we previously observed (Methods). Importantly, the 
correlations between discovery and replication Z-scores were strongest for associations 
found in the corresponding tissue (ρ=0.60, P=1.5×10−05 for blood/LCL; ρ=0.66, P=0.05 for 
adipose, Supplementary Table 13); a significant aggregate replication and further evidence 
for the tissue-specific nature of our findings. Using the larger, but heterogeneous, training 
sample from ref.11, 24 out of 37 available genes replicated significantly (Supplementary 
Table 9). Although these replications are not strictly independent (they use the same GWAS 
data), they demonstrate that many of the novel loci are consistently significant across 
diverse expression cohorts.
Functional analysis of the novel associations
To better understand their functional consequences, we evaluated the 69 novel genes in the 
Hybrid Mouse Diversity Panel (HMDP) for correlation with multiple obesity-related traits. 
This panel includes 100 inbred mice strains with extensive collection of obesity-related 
phenotypes from ~12,000 genes. Of the 69 novel TWAS genes previously identified, 40 
were present in the panel and could be evaluated for effect on phenotype. Of these, 26 were 
significantly associated with at least one obesity-related trait (after accounting for genes 
tested) and 14 remained significant after accounting for 36 phenotypes tested (very 
conservatively assuming the phenotypes were independent) (Supplementary Table 14). 77% 
of the genes with an association were associated with multiple phenotypes. For example, 
expression of Ftsj3 was significantly correlated with fat mass, glucose-to-insulin ratio, and 
body weight in both liver and adipose tissue, with R2 ranging from 0.20–0.28. Another 
candidate, Iih4, was significantly correlated with LDL and TC levels in liver. In humans, 
this gene is also linked to hypercholesterolemia in OMIM and was previously associated 
with BMI in East Asians41. Due to complex correlation of phenotypes, it is difficult to 
assess whether this gene set is significant in aggregate and genes in the HMDP are typically 
expected to have strong effects. We could not perform enough random selections of genes to 
Gusev et al. Page 8
Nat Genet. Author manuscript; available in PMC 2017 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
establish significance for this set. However, we consider the 26 individually significant 
genes to be fruitful targets for follow-up studies.
The BMI and height GWAS evaluated functional enrichment at identified loci, and we 
performed similar analyses for the novel genes that we identified. We tested the 10 novel 
BMI genes and 33 novel height genes for tissue-specific enrichment using DEPICT42, a 
method based on large-scale gene co-expression analyses, following the protocol of the 
original GWAS studies6,7. Analysis of BMI identified significant enrichment for 
hypothalamus and neurosecretory systems (P=2.6×10−4, significant at FDR<5%). This 
enrichment is consistent with the landmark finding in the original study6 showing 
enrichment in these and other central nervous system tissues. Notably, we recapitulated this 
result using only novel genes that did not overlap any genome-wide significant SNPs. In 
analysis of height, DEPICT did not identify any tissue-specific enrichment.
Discussion
In this work we proposed methods that integrate genetic and transcriptional variation to 
identify genes with expression associated to complex traits. Using imputed gene expression 
to guide GWAS has three potential advantages. First, the gene is a more interpretable 
biological unit than an associated locus, which often contains multiple significant SNPs in 
LD that may not lie in genes and/or tag variants in multiple genes. Second, the lower total 
number of genes (or cis-heritable genes) means the multiple-testing burden is substantially 
reduced relative to all SNPs. Lastly, combining cis-SNPs into a single predictor may capture 
heterogeneous signal better than individual SNPs or cis-eQTLs. Focusing the prediction on 
the genetic component of expression also avoids confounding from environmental 
differences caused by the trait that may impact expression. Our approach builds upon the 
wealth of GWAS data in massive cohorts to directly implicate the gene-based mechanisms 
underlying complex traits.
Our proposed method shares conceptual similarities with 2-sample Mendelian 
randomization approaches that aim to identify causal relations between traits using genetic 
variation predictions as a randomizer43–45. However, while Mendelian randomization is 
intended to quantify the total causal effect, our method has the less strict goal of identifying 
significant associations and can operate on summary GWAS data. Importantly, our approach 
maintains the attractive feature of not being confounded by effects on expression and trait 
that are independent of the SNPs. Other recent work proposed to leverage summary statistics 
to estimate the underlying genetic correlation between traits at the genome-wide level37, but 
cannot be applied locally as it requires multiple loci to estimate standard errors (Methods). 
Recent work in parallel to ours also proposes gene expression imputation from individual-
level data to find expression-trait associations and observes benefits from a reduced 
multiple-testing burden and increased interpretability16. In contrast, our approach does not 
require individual GWAS data and is applicable directly to GWAS summary data of very 
large sample sizes thus increasing discovery power.
Unlike current methods, which focus on individually significant eQTL and SNP 
associations5,6,8,9,11,13,26,29, our approach captures the full cis-SNP signal and does not 
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require any individual marker to be significant. This is underscored by the fact that TWAS 
substantially outperformed its cis-eQTL analog both in imputing expression and in 
association to trait. Our results show that the imputation approach is especially effective 
when multiple variants influence expression (which in turn influences trait). The large 
number of new associations identified in real data supports this phenomenon and suggests 
that it may be a strong contributor to common phenotypes46. Therefore, our approach can be 
seen as complementary to GWAS by identifying expression-trait associations that are not 
well explained by individual tagging SNPs. Future work could leverage the difference in 
performances of TWAS and GWAS to explicitly detect allelic heterogeneity. We note that it 
is still possible for some loci to have an independent SNP-phenotype and SNP-expression 
association driven by the same underlying variant though we consider this to be an 
infrequent biological model.
We conclude with several limitations of our approach. First, disease-impacting variants that 
are independent of cis-expression – in general or in the training data – will not be identified. 
Second, as with any prediction, the number of genes that can be accurately imputed is still 
limited by the training cohort size and the quality of the training data. In particular, we 
found that prediction accuracy did not correspond to theoretical expectations and is likely 
driven by data quality. The impact of these weaknesses could be better quantified as 
expression from larger sample sizes and a more diverse set of tissues becomes available. 
Although in this work we utilized both microarray and RNA-seq as measure of gene 
expression thus showcasing the applicability of our approach to diverse data sets, the 
accuracy of our method intrinsically depends on the quality of the expression measurements. 
For the associated genes, it remains possible that the effect is actually mediated by 
phenotype (i.e. SNP → phenotype → cis-expression, Figure 2F). We attempted to quantify 
this in the YFS data by conditioning the heritability analyses on all the evaluated phenotypes 
(height, BMI, and lipids) but observed no significant change at individual genes or in the 
mean . These results suggest that confounding from phenotype does not substantially 
affect the tested cis expression, though at the current sample size we cannot completely rule 
out such confounders for individual genes. An alternative confounder arises from 
independent effects on phenotype and expression at the same SNP/tag (Figure 2G, 
Methods). Such instances could be indistinguishable from the desired causal model 
(Methods) without analyzing individual-level data, though we believe they are still 
biologically interesting cases of co-localization. Both types of confounding could potentially 
be quantified by training the SNP-expression relationships in control individuals where 
phenotype is fixed, or by interrogating the gene experimentally. Lastly, the summary-based 
TWAS cannot account for rare variants that are poorly captured by the LD reference panel, 
or optimally capture non-linear relationships between SNPs and expression. Additional 
sources of information could potentially be incorporated to improve the prediction, 
including significant trans-associations11,28; allele-specific expression47,48; splice-QTLs 
effecting individual exons10; haplotype effects; and SNP-specific functional priors20,49–51.
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Online Methods
Data sets
In this study, we included 11,484 participants from two Finnish population cohorts, the 
METabolic Syndrome in Men (METSIM, n=10,197)52,53 and the Young Finns Study (YFS, 
n=1,414)22,23. 1,400 randomly selected individuals from the 10,197 METSIM participants 
underwent a subcutaneous abdominal adipose biopsy of which 600 RNA samples were 
analyzed using RNA-seq (Supplementary Note). Traits BMI, TG, WHR, and INS were 
inverse rank transformed and adjusted for age and age-square. INS was additionally adjusted 
for T1D and T2D. 1,414 individuals (638 men with a median age of 43 years and 776 
women with a median age of 43) with gene expression, phenotype, and genotype data 
available were included in the blood expression analysis. Traits height, BMI, TG, TC, HDL, 
and LDL were inverse rank transformed and adjusted for age, age-square, and sex. TC was 
also adjusted for Statin intake. The biochemical lipid, glucose, and other clinical and 
metabolic measurements of METSIM and YFS were performed as described 
previously22,52,54. Complete details on the pipeline and quality control procedures can be 
found in Supplementary Note.
Heritability estimation with individual data
Cis and trans variance components were estimated using the REML algorithm implemented 
in GCTA19. As in previous studies, estimates were allowed to converge outside the expected 
0–1 bound on variance to achieve unbiased mean estimates across all genes24. Standard 
error across gene sets was estimated by dividing the observed standard deviation by the 
square root of the number of genes that converged (this will lead to underestimation due to 
correlated genes, but is presented for completeness). Genome-wide h2g for the four traits in 
the GWAS cohort was estimated with GCTA from a single relatedness matrix constructed 
over all post-QC SNPs in the strictly unrelated individuals. For estimating expression-wide 
h2GE, each predicted expression value was standardized to mean=0 and variance=1, and 
sample covariance across these values used to define the relatedness matrix. The  was 
then estimated from this component with GCTA, with P-values for difference from zero 
computed using a likelihood ratio test. 20 principal components (PCs) were always included 
as fixed-effects to account for ancestry. Genetic correlation between traits in the GWAS 
cohort was estimated from all post-QC SNPs in the full set of 10,000 individuals with 
GEMMA31 (Supplementary Table 15). For the YFS, we quantified the mediating effects of 
trait on cis-expression by separately re-estimating cis-h2g with all analyzed traits (height, 
BMI, TC, TG, HDL, LDL) included as fixed-effects in addition to PCs. We did not observe 
significant differences in any individual gene (after accounting for 3,836 genes tested) nor in 
the mean estimate of cis-h2g.
Heritability estimation with summary data
As shown in ref.51,55, for an association study of N independent samples, the expected χ2 
statistic is E[χ2] = 1 + Nlh2GE/M, where l is the LD-score accounting for correlation, M is 
the number of markers, and h2GE is the variance in trait explained by the imputed 
expression. We estimated l directly from the genetic values of expression to be close to 
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independence (1.4, 1.5 for METSIM, YFS) allowing us to solve for h2GE from the observed 
distribution of χ2 (or, asymptotically equivalent Z2) statistics. We did not compute this value 
for the BMI GWAS because the conservative multiple GC-correction applied in that study 
would yield a severe downwards bias6.
Imputing expression into genotyped samples
We evaluated three prediction schemes: i. cis-eQTL, the single most significantly associated 
SNP in the training set was used as the predictor; ii. the best linear predictor (BLUP)30, 
estimates the causal effect-sizes of all SNPs in the locus jointly using a single variance-
component; iii. The Bayesian linear mixed model (BSLMM)31, which estimates the 
underlying effect-size distribution and then fits all SNPs in the locus jointly. For the BLUP 
and BSLMM, prediction was done over all post-QC SNPs using GEMMA31. We note that 
the BLUP/BSLMM both perform shrinkage of the SNP weights but not variable selection, 
so all SNPs are included in the predictor. Recent work in parallel to ours also evaluated 
expression imputation using polygenic risk scores, LASSO, and elastic net16.
Evaluating prediction accuracy
Within-study prediction accuracy was measured by five-fold cross-validation in a random 
sampling of 1,000 of the highly heritable genes (i.e. significant non zero cis-heritability) for 
each study. Cross-study prediction accuracy was measured by merging the YFS/NTR 
genotyped individuals and predicting from all individuals in one cohort into all individuals 
in the other. In all instances, the R2 between predicted and true expression across all 
predicted folds was used to evaluate accuracy (see Supplementary Note).
Imputing expression into GWAS summary statistics
Summary-based imputation was performed using the ImpG-Summary algorithm4 extended 
to train on the cis-genetic component of expression. Let Z be a vector of standardized effect 
sizes (z-scores) of SNP on trait at a given cis-locus (i.e. Wald statistics β/se(β) ). We impute 
the z-score of the expression and trait as a linear combination of elements of Z with weights 
W (these weights are precompiled from the reference panel as Σe,sΣ−1s,s for ImpG-
Summary or directly from BSLMM). Σe,s is the covariance matrix between all SNPs at the 
locus and gene expression and Σs,s is the covariance among all SNPs (i.e. linkage 
disequilibrium). Under null data (no association) and a multi-variate normal assumption Z ~ 
N(0,Σs,s). It follows that imputed z-score of expression and trait (WZ) has variance W Σs,s 
Wt; therefore, we use WZ/(W Σs,s Wt )1/2 as the imputation Z-score of cis-genetic effect on 
trait. In practice, for each gene, all SNPs within 1Mb of the gene present in the GWAS study 
were selected, and Σs,s and Σe,s were computed in the reference panel (i.e. expression and 
SNP data). To account for finite sample size and instances where Σs,s is not invertible, we 
adjusted the diagonal of the matrix using a technique similar to ridge regression with λ=0.1 
(as evaluated in Pasaniuc et al4). This regularization, as well as noise in the estimation of W, 
can translate to lower power for association but yield conservative imputed Z-statistics.
We used the YFS samples that were assayed for SNPs, phenotype, and expression to assess 
the consistency of individual-level and summary-based TWAS. We first computed GWAS 
association statistics between phenotype (height) and SNP and used them in conjunction 
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with the expression data to impute summary-based TWAS statistics. The TWAS statistics 
were compared to those from the simple regression of (height ~ expression) in the YFS data. 
We observed a correlation of 0.415 (Supplementary Figure 5), consistent with an average 
cis-h2g of 0.17 (≈0.415^2) observed for these genes. When restricting to a regression of 
(height ~ cis component of expression) we observed a correlation of 0.998 to the summary 
based TWAS, demonstrating the equivalence of the two approaches when using in-sample 
LD.
Power analysis of summary-based method
Simulations to evaluate the summary-based method were performed in 6,000 unrelated 
METSIM GWAS individuals. 100 genes and the SNPs in the surrounding 1MB were 
randomly selected for testing. For each gene, normally distributed gene expression was 
simulated as E = Xβ + ε; where X is a matrix of the desired number of causal genotypes, 
sampled randomly from the locus; β is a vector of normally distributed effect-sizes for each 
causal variant; and ε is a vector of normally distributed noise to achieve a cis-h2g of 0.17 
(corresponding to the mean observed in our significant gene sets). 1,000 individuals with 
SNPs and simulated expression were then withheld for training the predictors. For the 
remaining 5,000 individuals, normally distributed noise was applied to the expression to 
generate a heritable phenotype where expression explained 0.10/180 or 0.20/180 of the 
phenotypic variance (the former corresponding to the average effect-sizes for associated 
genes observed in a large GWAS of height56 and the latter to high-effect loci). Association 
between SNP and phenotype was estimated in the 5,000 individuals (standard Z-score), and 
the phenotype generation repeated with different environmental noise (up to 60 times) to 
generate results from multiple GWAS sub-studies. Association statistics from each run were 
then meta-analyzed to reach precision corresponding to a larger GWAS of desired size (up 
to 300,000) (Supplementary Note).
Detecting a locus was defined as follows. The single most significant trait associated SNP 
was taken as the GWAS association, considered detected if GWAS significance was 
<5×10−8. The single most significant eQTL in the training set was taken as the eQTL-guided 
association (eGWAS), and considered detected if GWAS significance was <0.05/15,000. 
The TWAS association was measured by training the imputation algorithm on the 1,000 
held-out samples with expression and imputing into the GWAS summary statistics, and 
considered detected if significance was <0.05/15,000. The entire procedure was repeated 
500 times (5 per gene) and power was estimated by counting the fraction of instances where 
each method detected the locus. As in the cross-validation analysis, training on the genetic 
component of expression instead of the overall expression consistently increased TWAS 
power by ~10% (Supplementary Figure 7). Two null expression models were tested by 
generating gene expression for the 1,000 held-out samples that was standard normal as well 
as heritable expression (cis-h2g=0.17) with GWAS Z-scores drawn from the standard 
normal (Supplementary Table 4). See Supplementary Note for detailed simulation setup.
Power comparison to COLOC
COLOC uses summary data from eQTL and GWAS studies and a Bayesian framework to 
identify the subset of GWAS signals that co-localize with eQTLs. We sought to compare 
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TWAS to the COLOC-estimated posterior probability of association (PPA) being shared for 
both phenotypes (PP4 in the COLOC implementation). COLOC additionally evaluates the 
hypothesis of multiple independent associations (PP3), but this is more general than the 
proposed TWAS model and was not tested. Because COLOC relies on priors of association 
to produce posterior probabilities of co-localization, we sought to identify a significance 
threshold that would make a fair comparison to the TWAS p-value-based threshold. 
Specifically, we ran both methods on a realistic null expression simulation (with the 
generative model described previously): the expression was sampled from a null standard 
normal for 1,000 individuals and eQTLs computed; the trait associations were derived from 
a simulated 300,000 GWAS with a single typed causal variant that explained 0.001 variance 
of the trait (high effect). We believe this scenario is both realistic and consistent with the 
GWAS assumptions of COLOC. We then empirically identified the statistical threshold for 
COLOC and TWAS that would yield a 5% false discovery rate: co-localization statistic PP4 
> 0.17 for COLOC, and P<0.05 for TWAS. We note that this empirical COLOC threshold is 
much less stringent than PP4>0.8 used in the COLOC paper (PP4>0.8 would yield lower 
power for COLOC in our simulations). These thresholds were subsequently to evaluate the 
power to detect an expression-trait association in simulations with a true effect 
(Supplementary Figures S10, 12). The reported power is for a single locus and we did not 
attempt to quantify genome/transcriptome-wide significance.
Individual-level analysis of METSIM GWAS
We imputed the significantly heritable genes into the METSIM GWAS cohort of 5,500 
unrelated individuals with individual-level genotypes (and unmeasured expression). We then 
tested the imputed expression for obesity-related traits: body mass index (BMI); 
triglycerides (TG); waist-hip-ratio (WHR); and fasting insulin levels (INS). Overall, the 
evaluated traits exhibited high phenotypic and genetic correlation as well as highly 
significant genome-wide h2g ranging from 23–36% (Supplementary Table 15) consistent 
with common variants having a major contribution to disease risk1. Association was 
assessed using standard regression as well as a mixed-model that accounted for relatedness 
and phenotypic correlation31 with similar results. The effective number of tests for each trait 
was estimated by permuting the phenotypes 10,000 times and, for each permutation, re-
running the association analysis on all predicted genes. For each trait Pperm, the P-value in 
the lowest 0.05 of the distribution, was computed and the effective number of tests was 
0.05/Pperm, reported in Supplementary Table 16. All phenotypes were shuffled together, so 
any phenotypic correlation was preserved. The effective number of tests corresponded to 
88–95% of the total number of genes, indicating a small amount of statistical redundancy 
(Supplementary Note). To evaluate the TWAS approach, we computed phenotype 
association statistics for the 5,500 unrelated individuals and re-ran the analysis using only 
these summary statistics and the same expression reference panels. The resulting TWAS 
associations were nearly identical to the direct TWAS associations across the four traits 
(Pearson ρ=0.96). Reassuringly, the TWAS was generally more conservative than the direct 
estimates (Supplementary Figure 16).
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Refining trait-associated genes at known loci
We focused on GWAS data from height7 that identified 697 genome-wide significant 
variants in 423 loci, and conducted the summary-based TWAS over all genes in these loci 
using YFS and NTR as expression training data. Because the YFS individuals had been 
phenotyped for height and not tested in the GWAS, we could directly evaluate whether 
selected genes were associated with phenotype. At each locus, we considered three 
strategies for selecting a single causal gene: 1) the gene nearest to the most significantly 
associated SNP; 2) the gene for which the index SNP is the strongest eQTL in the training 
data; 3) the most significant TWAS gene. For each strategy, we then constructed a risk-score 
using the genetic value of expression for the selected gene weighted by the corresponding 
TWAS Z-score. The same procedure was then re-evaluated using TWAS values trained in 
the NTR cohort (which introduces additional noise due to heterogeneity between the 
cohorts, Supplementary Table 5).We separately used GCTA to estimate the heritability of 
height explained by all of the genes selected by each algorithm by constructing a GRM from 
the selected genes. In contrast to the risk score, this does not assume pre-defined weights on 
each gene but allows them to be fit by the REML model. Results were comparable, with 
only the TWAS-selected genes explaining significantly non-zero heritability 
(Supplementary Table 5).
Validation analysis in lipid GWAS data
We evaluated the performance of TWAS by identifying significantly associated genes in the 
2010 lipid study that did not overlap a genome-wide significant SNP, and looking for newly 
genome-wide significant SNPs in the expanded 2013 study. The P-value for the number of 
genes with increased significance and genome-wide significance in the 2013 study was 
computed by a hypergeometric test, with background probabilities estimated from the set of 
significantly heritable genes. Of the genes not overlapping a significant locus in the 2010 
study, 70% had a more significant SNP in the 2013 study and 3.5% overlapped a genome-
wide significant SNP (P<5×10−08).
Meta-analysis of imputed expression from multiple tissues
We proposed a novel omnibus test for significant association across predictions from all 
three cohorts. Because the imputation is made into the same GWAS cohort, correlation 
between predictors must be accounted for. For each gene i, we estimated a correlation 
matrix Ci by predicting from the three tissues into the ~5,500 unrelated METSIM GWAS 
individuals (though any large panel from the study population could be used). This 
correlation includes both the genetic correlation of expression as well as any correlated error 
in the predictors, thus capturing all redundancy. On average, a correlation of 0.01, 0.01, and 
0.43 was observed between YFS:METSIM, NTR:METSIM, and YFS:NTR, highlighting the 
same tissue of origin the last pair. We then used the three-entry vector of TWAS predictions, 
Zi, to compute the statistic omnibusi = Zi′ Ci−1 Zi which is approximately χ2 (3-dof) 
distributed and provides an omnibus test for effect in any tissue while accounting for 
correlation57,58. Though the correlation observed in our data was almost entirely driven by 
the YFS:NTR blood datasets, we expect this to be an especially useful strategy for future 
studies with many correlated tissues. An alternative approach would be to perform 
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traditional meta-analysis across the three cohorts and then predict the TWAS effect. 
However, this would lose power when true eQTL effect-sizes (or LD) differ across the 
cohorts, which we have empirically observed to be the case looking at predictor correlations 
above. The proposed omnibus test aggregates different effects across the studies, at the cost 
of additional degrees of freedom.
Gene permutation test
The standard TWAS Z-score is a test against the null of no SNP-trait association; that is 
ZTWAS = WZ/(W Σs,s Wt )1/2 is well calibrated (i.e. has a 0 mean and unit variance) only 
under the null model of Z ~ N(0,Σs,s). In the alternate model where Z is drawn from a non-
zero mean distribution59,60, ZTWAS has a distribution that depends both on Z as well as the 
weights W. To quantify the impact of the weights on ZTWAS regardless of whether Z is null 
or non-null we conduct permutations conditional on the observed Z vector. For each gene, 
the expression labels were randomly shuffled and the summary-based TWAS analysis 
trained on the resulting expression to compute a permuted new null for ZTWAS. Testing 
against this permuted null distribution is equivalent to testing for an expression-trait 
association (or genetic correlation between expression and trait, see below) conditional on 
the observed GWAS statistics at the locus (which may not be drawn from the null of no 
association). The permutation test empirically computes this distribution of ZTWAS values 
conditional on the observed Z and asks how extreme is the observed ZTWAS among all 
possible W coming from permuted expression data. Note that failing the permutation test 
may be an indication of lack of power to show that the expression significantly refines the 
direct SNP-trait signal. In practice, the permutation test was run 1,000 times for each TWAS 
gene and a p-value computed by Z-test against this null.
Relationship to genetic covariance/correlation
Our tests relate to previously defined estimators of genetic correlation and covariance 
between traits. We consider two definitions of genetic covariance at a locus: 1) the 
covariance between the genetic component of expression and the genetic component of trait; 
2) the covariance between the causal effect sizes for expression and the causal effect-sizes 
for trait. Under assumptions of independent effect-sizes, these definitions yield 
asymptotically identical quantities37. Assuming a substantially large training set where the 
genetic component of expression can be perfectly predicted, the direct TWAS tests for a 
significant association between the genetic component of expression and the trait; equivalent 
to testing definition #1 for a polygenic trait. Likewise, the summary-based TWAS tests for a 
significant sum of products of the causal expression effect sizes and the causal trait effect 
sizes; equivalent to definition #2 up to a scaling factor. The TWAS approach therefore fits 
naturally with the broader study of shared genetic etiology of multiple phenotypes. At the 
sample sizes evaluated in this study, the TWAS approach is substantially better powered 
than an LD-based estimate of local genetic correlation (Supplementary Note).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Overview of methods
Cartoon representation of TWAS approach. In the reference panel (top) estimate gene 
expression effect-sizes: directly (i.e. eQTL); modeling LD (BLUP); or modeling LD and 
effect-sizes (BSLMM). A: Predict expression directly into genotyped samples using effect-
sizes from the reference panel and measure association between predicted expression and 
trait. B: Indirectly estimate association between predicted expression and trait as weighted 
linear combination of SNP-trait standardized effect sizes while accounting for LD among 
SNPs.
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Figure 2. Modes of expression causality
Diagrams are shown for the possible modes of causality for the relationship between genetic 
markers (SNP, blue), gene expression (GE, green), and trait (red). A–D describes scenarios 
that would be considered null by the TWAS model; E–G describes scenarios that could be 
identified as significant.
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Figure 3. Number of genes with significant cis-heritability observed at varying sample sizes
The number of genes with significant cis-heritability was estimated by down-sampling each 
cohort (YFS, METSIM, and NTR/Wright et al.) into quintiles.
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Figure 4. Accuracy of direct expression imputation algorithms
Adjusted accuracy was estimated using cross-validation R^2 between prediction and true 
expression, and normalized by corresponding cis-h2g. Bars show mean estimate across three 
cohorts and three methods: eQTL – single best cis-eQTL in the locus; BLUP using all SNPs 
in the locus; BSLMM using all SNPs in the locus and non-infinitesimal priors.
Gusev et al. Page 23
Nat Genet. Author manuscript; available in PMC 2017 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 5. Power of summary-based expression imputation algorithms
Realistic disease architectures were simulated and power to detect a genome-wide 
significant association evaluated across three methods (accounting for 15,000 eGWAS/
TWAS tests, and 1,000,000 GWAS tests). Colors correspond number of causal variants 
simulated and methods used: GWAS where every SNP in the locus is tested; eGWAS where 
only the best cis-eQTL is tested; and TWAS computed using summary-statistics. Expression 
reference panel was fixed at 1,000 out-of-sample individuals and simulated GWAS sample 
size designated by x-axis. Power was computed as the fraction of 500 simulations where 
significant association was identified.
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